Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Therapy in High-Risk Newly Diagnosed Multiple Myeloma

Tan, C; Korde, N; Derkach, A; Hultcrantz, M; Maclachlan, KH; Hassoun, H; Mailankody, S; Shah, UA; Rajeeve, S; Patel, D; Lesokhin, A; Lahoud, OB; Shah, GL; Scordo, M; Chung, D; Landau, H; Giralt, SA; Hofmeister, CC; Kaufman, JL; Nooka, AK; Usmani, SZ; Lonial, S; Joseph, NS

BLOOD, 2023; 142 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索